INDOCO REMEDIES
Back to Balance Sheet
|
INDOCO REMEDIES Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Deferred Tax Assets / Liabilities | ₹13 Cr | ₹12 Cr | ₹6.14 Cr | ₹11 Cr | ₹-19 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of INDOCO REMEDIES ?
| Year | Deferred Tax Assets / Liabilities |
|---|---|
| Mar2025 | ₹13 Cr |
| Mar2024 | ₹12 Cr |
| Mar2023 | ₹6.14 Cr |
| Mar2022 | ₹11 Cr |
| Mar2021 | ₹-19 Cr |
How is Deferred Tax Assets / Liabilities of INDOCO REMEDIES Trending?
| Years | Deferred Tax Assets / Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹13 Cr | 12.93 | |
| Mar2024 | ₹12 Cr | 92.58 | |
| Mar2023 | ₹6.14 Cr | -42.06 | |
| Mar2022 | ₹11 Cr | Positive | |
| Mar2021 | ₹-19 Cr | - | |
Compare Deferred Tax Assets / Liabilities of peers of INDOCO REMEDIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| INDOCO REMEDIES | ₹1,891.7 Cr | -8.8% | -4.7% | -23.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹410,442.0 Cr | 0.5% | -1.5% | -2.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹171,878.0 Cr | 5.5% | -0.2% | 0.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹137,301.0 Cr | 2.1% | 2.8% | 30.9% | Stock Analytics | |
| CIPLA | ₹109,030.0 Cr | 1.3% | -7.9% | -6.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,023.0 Cr | 2% | 4.5% | 2.3% | Stock Analytics | |
INDOCO REMEDIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| INDOCO REMEDIES | -8.8% |
-4.7% |
-23.9% |
| SENSEX | 0.5% |
0.8% |
7.2% |
You may also like the below Video Courses